{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:56:06Z","timestamp":1790034966057,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1624,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41379-018-0041-7","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:04:58Z","timestamp":1522793098000},"page":"1332-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas"],"prefix":"10.1016","volume":"31","author":[{"given":"Sarah","family":"Menguy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Frison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Prochazkova-Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boulinguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dalac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Machet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ram-Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Verneuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-0850","authenticated-orcid":false,"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Ledard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-018-0041-7_bib1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European organization for research and treatment of cancer and international society for cutaneous lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian study group for cutaneous lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib6","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cam4.865","article-title":"Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers","volume":"5","author":"Lucioni","year":"2016","journal-title":"Cancer Med"},{"key":"10.1038\/s41379-018-0041-7_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/DAD.0b013e3181eeb433","article-title":"The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases","volume":"33","author":"Plaza","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/s41379-018-0041-7_bib8","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO\u2013EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1038\/s41379-018-0041-7_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-018-0041-7_bib13","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/PAS.0000000000000851","article-title":"Tumor microenvironment and checkpoint molecules in primary cutaneous diffuse large B-cell lymphoma\u2014New therapeutic targets","volume":"41","author":"Mitteldorf","year":"2017","journal-title":"Am J Surg Path"},{"key":"10.1038\/s41379-018-0041-7_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2008.30","article-title":"Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal centre derivation of primary cutaneous follicular lymphoma","volume":"21","author":"Xie","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5858\/arpa.2014-0018-CP","article-title":"Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphoma","volume":"139","author":"Dewar","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-018-0041-7_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 society for hematopathology\/European association for haematopathology workshop","volume":"139","author":"Swerdlow","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/his.12855","article-title":"Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform","volume":"69","author":"Robson","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-018-0041-7_bib20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib21","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/his.12884","article-title":"MYC\/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis","volume":"68","author":"Li","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-018-0041-7_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2016-02-636316","article-title":"Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and\/or BCL6 rearrangements","volume":"129","author":"Sesques","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib24","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib25","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with Rituximab plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib26","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood-2015-10-676700","article-title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","volume":"127","author":"Savage","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib27","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the international DLBCL Rituximab-CHOP consortium program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.0022-202X.2003.12635.x","article-title":"Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas","volume":"122","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib33","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/DAD.0000000000000738","article-title":"An aggressive primary cutaneous follicle centre lymphoma with c-MYC translocation and CDKN2A (9p21) deletion: a case report and review of the literature","volume":"39","author":"Tsang","year":"2017","journal-title":"Amn J Dermatopathol"},{"key":"10.1038\/s41379-018-0041-7_bib34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.pas.0000155163.40668.e7","article-title":"Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases","volume":"29","author":"Wiesner","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.pas.0000126775.27698.6e","article-title":"Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle centre B-cell lymphomas","volume":"28","author":"Vergier","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000567","article-title":"Primary cutaneous follicle centre lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases","volume":"40","author":"Szablewski","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib38","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German high-grade non-Hodgkin's lymphoma study group (DSHNHL)","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"key":"10.1038\/s41379-018-0041-7_bib39","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1038\/s41379-018-0041-7_bib40","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of Rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib41","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/cncr.26433","article-title":"Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma","volume":"118","author":"Lin","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/s41379-018-0041-7_bib42","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"Quesada","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-018-0041-7_bib43","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1200\/JCO.2009.22.7058","article-title":"Immuno\u2013fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study","volume":"27","author":"Copie-Bergman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-018-0041-7_bib44","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-018-0041-7_bib45","doi-asserted-by":"crossref","unstructured":"Kim YJ, Won CH, Chang SE, et al. MYC protein expression is associated with poor prognosis in cutaneous diffuse large B-cell lymphoma. Australasian J Dermatol. https:\/\/doi.org\/10.1111\/ajd.12705.","DOI":"10.1111\/ajd.12705"},{"key":"10.1038\/s41379-018-0041-7_bib46","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/s41379-018-0041-7_bib47","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg-type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J Invest Dermatol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0041-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222011735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-018-0041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:46:53Z","timestamp":1760230013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222011735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0893395222011735"],"URL":"https:\/\/doi.org\/10.1038\/s41379-018-0041-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-018-0041-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}